Prescription drug · ANDA
Pilocarpine Hydrochloride NDC 72162-1078
Pilocarpine hydrochloride 5 mg/1 · Tablet, Film coated · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72162-1078-1 | 72162107801 | 100 TABLET, FILM COATED in 1 BOTTLE (72162-1078-1)Marketed from Dec 12, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Pilocarpine Hydrochloride
- Generic name (nonproprietary)
- pilocarpine hydrochloride
- Active ingredients
- Pilocarpine hydrochloride — 5 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077220
- Marketing start
- Listing expires
- Other FDA classes
- Cholinergic Agonists (Mechanism)Cholinergic Muscarinic Agonists (Mechanism)
- Identifiers
- Product ID 72162-1078_aa0c11f4-3998-4089-80b7-b6807c77ecd3SPL ID aa0c11f4-3998-4089-80b7-b6807c77ecd3SPL set ID 06c054af-62b4-4373-813a-9bb2e5c92316RxCUI 1000913UNII 0WW6D218XJ
- Pharmacologic class
- Cholinergic Receptor Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472162107801followed by a unit qualifier and the quantityPackage 72162-1078-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE: Pilocarpine hydrochloride tablets, USP are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with Sjogren's syndrome.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 077220
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 7.5 mg/1 | Tablet, Film coatedOral | Lannett Company, Inc. | 0527-1407 |
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 5 mg/1 | Tablet, Film coatedOral | AvPAK | 50268-652 |
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 5 mg/1 | Tablet, Film coatedOral | Lannett Company, Inc. | 0527-1313 |
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 5 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-2099 |
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 5 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-8351 |